Effectiveness and Safety of GLP-1 Drugs Like Ozempic and Wegovy Questioned

High costs and serious side effects spark concerns, despite their potential in treating obesity and diabetes.

Recent reports indicate that drugs like Ozempic and Wegovy, lauded for their weight loss capabilities, are not as effective for everyone, with a significant number of users not experiencing the expected weight loss.
The high cost of these medications in the US, compared to their production cost and international prices, has sparked controversy and calls for price reductions.
Serious side effects and a growing number of lawsuits related to GLP-1 drugs have raised concerns about their safety.
The discovery and development of GLP-1 drugs, including Ozempic and Wegovy, were inspired by research into the incretin effect and substances like lizard venom.
Despite the challenges, GLP-1 drugs represent a significant advance in the treatment of obesity and type 2 diabetes, with ongoing research into more effective and accessible formulations.